Article
The efficacy and safety of chemo-free therapy in epidermal growth factor receptor tyrosine kinase inhibitor-resistant advanced non-small cell lung cancer: A single-arm, phase II study.
Cancer medicine - 1 Oct 2023
Zhang Shuyang, Yang Lu, Yang Yaning, Yang Guangjian, Xu Haiyan, Niu Xueliang, Wang Yan
Abstract excerpt
OBJECTIVES: The purpose of this study was to explore the efficacy and safety of toripalimab combined with anlotinib in patients with advanced non-small cell lung cancer (NSCLC) who acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). MATERIALS AND METHODS: Patients who developed resistance after using first- or second-generation EGFR-TKIs as their first-line regimen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.